- Global Pharma News & Resources

Global Drug Delivery Technologies Market Analysis & Trends - Industry Forecast to 2027 -

The "Global Drug Delivery Technologies Market Analysis & Trends - Industry Forecast to 2027" report has been added to's offering.

The Global Drug Delivery Technology Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include growing demand for biosimilars and generic drugs and increasing incidence of chronic diseases and recent technological developments in drug delivery technology. This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries. Current Trends
  • Growing Demand for Biosimilars and Generic Drugs
  • Increasing Incidence of Chronic Diseases
  • Recent Technological Developments in Drug Delivery Technology
  • Growth Opportunities/Investment Opportunities

Key Topics Covered

1 Market Outline

2 Executive Summary

3 Market Overview

4 Drug Delivery Technology Market, By Route of Administration

5 Drug Delivery Technology Market, By End User

6 Drug Delivery Technology Market, By Geography

7 Key Player Activities

8 Leading Companies

  • 3M
  • Bayer AG
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • GlaxoSmithKline PLC
  • Roche Holding AG
  • Antares Pharma Inc.
  • Merck & Co. Inc.
  • Sanofi
  • Vectura Group PLC
  • Generex Biotechnology
  • Alkermes
  • Aradigm Corp.

For more information about this report visit

View source version on

Editor Details

Last Updated: 17-Dec-2018